1. Home
  2. CTKB vs FFA Comparison

CTKB vs FFA Comparison

Compare CTKB & FFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • FFA
  • Stock Information
  • Founded
  • CTKB 1990
  • FFA 2004
  • Country
  • CTKB United States
  • FFA United States
  • Employees
  • CTKB N/A
  • FFA N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • FFA Investment Managers
  • Sector
  • CTKB Health Care
  • FFA Finance
  • Exchange
  • CTKB Nasdaq
  • FFA Nasdaq
  • Market Cap
  • CTKB 450.9M
  • FFA 400.0M
  • IPO Year
  • CTKB 2021
  • FFA N/A
  • Fundamental
  • Price
  • CTKB $2.95
  • FFA $19.90
  • Analyst Decision
  • CTKB Hold
  • FFA
  • Analyst Count
  • CTKB 4
  • FFA 0
  • Target Price
  • CTKB $6.00
  • FFA N/A
  • AVG Volume (30 Days)
  • CTKB 1.6M
  • FFA 26.1K
  • Earning Date
  • CTKB 08-05-2025
  • FFA 01-01-0001
  • Dividend Yield
  • CTKB N/A
  • FFA 6.72%
  • EPS Growth
  • CTKB N/A
  • FFA N/A
  • EPS
  • CTKB N/A
  • FFA N/A
  • Revenue
  • CTKB $197,050,000.00
  • FFA N/A
  • Revenue This Year
  • CTKB $0.91
  • FFA N/A
  • Revenue Next Year
  • CTKB $7.75
  • FFA N/A
  • P/E Ratio
  • CTKB N/A
  • FFA N/A
  • Revenue Growth
  • CTKB N/A
  • FFA N/A
  • 52 Week Low
  • CTKB $2.37
  • FFA $15.84
  • 52 Week High
  • CTKB $7.63
  • FFA $19.30
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 42.71
  • FFA 59.54
  • Support Level
  • CTKB $3.16
  • FFA $19.78
  • Resistance Level
  • CTKB $3.72
  • FFA $20.05
  • Average True Range (ATR)
  • CTKB 0.20
  • FFA 0.16
  • MACD
  • CTKB 0.01
  • FFA -0.03
  • Stochastic Oscillator
  • CTKB 30.07
  • FFA 62.58

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About FFA First Trust Enhanced Equity Income Fund

First Trust Enhanced Equity Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide a high level of current income and gains and, to a lesser extent, capital appreciation. The Fund pursues its investment objective by investing in a diversified portfolio of equity securities.

Share on Social Networks: